Can Solumedrol (methylprednisolone) increase lactic acid levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Solumedrol Increase Lactic Acid Levels?

Yes, methylprednisolone (Solumedrol) can cause hyperlactatemia and lactic acidosis, though this is a rare adverse effect that represents type B (non-ischemic) lactic acidosis rather than tissue hypoperfusion.

Mechanism and Clinical Evidence

Methylprednisolone can induce elevated lactate levels through metabolic disturbances rather than tissue hypoxia. 1 This represents type B lactic acidosis, which occurs without hypoperfusion due to metabolic disturbances or drug toxicity. 2

  • Case documentation: A 19-year-old patient developed lactic acidosis shortly after receiving high-dose methylprednisolone for spinal cord injury, with lactate levels returning to baseline after steroid discontinuation. 1
  • Pediatric case: A 5-year-old with severe asthma developed lactic acidosis following treatment with methylprednisolone (along with theophylline and albuterol), confirmed by elevated serum lactate and increased anion gap. 3
  • Systematic review findings: Medication-induced lactate elevations are diagnoses of exclusion that can be overlooked, with 64% of cases classified as lactic acidosis and 16% mortality rate across all medication-induced cases. 4

Diagnostic Approach When Suspecting Steroid-Induced Lactic Acidosis

First, rule out type A (hypoperfusion) causes:

  • Assess hemodynamic status for shock, sepsis, or tissue hypoperfusion 2
  • Evaluate for circulatory disorders including cardiac failure 2
  • Check for severe infections, particularly in diabetic patients 2

Laboratory confirmation:

  • Arterial pH <7.35 with elevated anion gap (>16) suggests lactic acidosis 2
  • Blood lactate >2 mmol/L is elevated; >5 mmol/L is abnormal; >10 mmol/L is life-threatening 2
  • Calculate anion gap: Na - (Cl + CO₂) >16 2, 3
  • Use prechilled fluoride-oxalate tubes, transport on ice, and process within 4 hours 2

Exclude other medication causes:

  • Review for metformin use (especially with eGFR <30 mL/min/1.73m²) 5, 6
  • Check for nucleoside reverse transcriptase inhibitors in HIV patients 2
  • Consider other sympathomimetics like epinephrine or albuterol 4, 3

Management Strategy

Immediate actions:

  • Discontinue or reduce methylprednisolone dose if type B lactic acidosis is confirmed and type A causes are excluded 1
  • Continue supportive care while monitoring lactate trends 2
  • Do NOT use sodium bicarbonate for pH ≥7.15, as it does not improve hemodynamics and may worsen outcomes 2

Monitoring approach:

  • Repeat lactate measurement within 6 hours to assess trend 2
  • Monitor for progression or resolution after steroid adjustment 1
  • Watch for clinical symptoms: gastrointestinal distress, tachypnea, dyspnea, weakness, or confusion 2

Critical Clinical Pitfalls

Do not assume all lactic acidosis is from hypoperfusion. Type B lactic acidosis from medications can occur in hemodynamically stable patients with normal tissue perfusion. 1 The combination of methylprednisolone with other agents (theophylline, beta-agonists) may compound the risk. 3

Do not delay recognition. Subtle early symptoms like nonspecific gastrointestinal complaints, dyspnea, and generalized weakness often precede severe acidosis and should prompt lactate measurement. 2

Consider the clinical context. In patients receiving high-dose methylprednisolone who develop unexplained lactate elevation without signs of shock or sepsis, medication-induced type B lactic acidosis should be high on the differential. 1 Pharmacists should be consulted as they are well-positioned to identify medication-induced lactate elevations. 4

References

Guideline

Lactic Acidosis Causes and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lactic Acidosis Risk Comparison

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.